US Patent 7172752 Combination particles for the treatment of asthma

Patent 7172752 was granted and assigned to Orion Corporation on February, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+5 properties)

Infobox

Patent Inventor Names

David Brown0

Esa Muttonen0

Esko Kauppinen0

Petri Ahonen0

Wiwik Watanabe0

Edits on 31 Aug, 2023

"Add patent abstract"

Golden AI

edited on 31 Aug, 2023

Edits made to:

Article (+523 characters)

Article

Patent abstract

Inhalation particles incorporating, in an individual particle, a combination of a βhd 2-agonist and a glucocorticosteroid in a predetermined and constant ratio, a process for the preparation thereof and pharmaceutical compositions comprising the inhalation particles. The particles have a narrow particle size distribution and are preferably in the form of spherical crystalline particles with a rough surface. The particles are particularly useful in the treatment of asthma and other respiratory disorders.

Edits on 22 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=071727520

Edits on 18 May, 2023

"Remove leading 0 from patent number"

Golden AI